Bank of America’s Kazia Therapeutics KZIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4
| Closed | -$199 | – | 8119 |
|
|
2023
Q3 | $199 | Hold |
4
| – | – | ﹤0.01% | 7411 |
|
|
2023
Q2 | $232 | Hold |
4
| – | – | ﹤0.01% | 7373 |
|
|
2023
Q1 | $206 | Buy |
+4
| New | +$192 | ﹤0.01% | 7429 |
|
|
2022
Q2 | – | Sell |
-2
| Closed | -$1K | – | 8210 |
|
|
2022
Q1 | $1K | Buy |
+2
| New | +$715 | ﹤0.01% | 8115 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8441 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8260 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7915 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7606 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7231 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7039 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6977 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7059 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7249 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7374 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7305 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7265 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7240 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7372 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7207 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7223 |
|
|
2017
Q4 | – | Sell |
-4
| Closed | -$591 | – | 7141 |
|
|
2017
Q3 | $0 | Buy |
4
+3
| +300% | +$477 | ﹤0.01% | 7161 |
|
|
2017
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7063 |
|
|
2017
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7121 |
|
|
2016
Q4 | $0 | Sell |
1
-444
| -100% | -$149K | ﹤0.01% | 7181 |
|
|
2016
Q3 | $173K | Hold |
445
| – | – | ﹤0.01% | 5196 |
|
|
2016
Q2 | $166K | Sell |
445
-1
| -0.2% | -$430 | ﹤0.01% | 5301 |
|
|
2016
Q1 | $220K | Buy |
446
+1
| +0.2% | +$422 | ﹤0.01% | 5094 |
|
|
2015
Q4 | $186K | Buy |
445
+425
| +2,125% | +$208K | ﹤0.01% | 5421 |
|
|
2015
Q3 | $10K | Hold |
20
| – | – | ﹤0.01% | 6567 |
|
|
2015
Q2 | $16K | Hold |
20
| – | – | ﹤0.01% | 6423 |
|
|
2015
Q1 | $17K | Sell |
20
-5
| -20% | -$2.87K | ﹤0.01% | 6111 |
|
|
2014
Q4 | $10K | Hold |
25
| – | – | ﹤0.01% | 7056 |
|
|
2014
Q3 | $15K | Buy |
25
+5
| +25% | +$3.21K | ﹤0.01% | 7174 |
|
|
2014
Q2 | $15K | Hold |
20
| – | – | ﹤0.01% | 7287 |
|
|
2014
Q1 | $16K | Sell |
20
-13
| -39% | -$11.1K | ﹤0.01% | 7008 |
|
|
2013
Q4 | $28K | Sell |
33
-10
| -23% | -$9.62K | ﹤0.01% | 6872 |
|
|
2013
Q3 | $35K | Hold |
43
| – | – | ﹤0.01% | 6621 |
|
|
2013
Q2 | $39K | Buy |
+43
| New | +$38.7K | ﹤0.01% | 6696 |
|
Other funds holding KZIA
AC
PIM
TSS
XT
Bank of America's KZIA Position: Q4 2023 in Review
Bank of America sold out of Kazia Therapeutics (KZIA) in Q4 2023, closing a stake of 4 shares — an estimated $199 sold.
Bank of America first reported a position in KZIA in Q2 2013 and held it in 22 quarters. The position peaked at $220K in Q1 2016. 17 funds tracked by Wall St. Rank hold KZIA as of Q4 2023.
- Bank of America reported no remaining Kazia Therapeutics position as of Q4 2023 after selling out during the quarter.
- Bank of America sold 4 Kazia Therapeutics shares in Q4 2023, an estimated $199.
- Bank of America first reported a position in Kazia Therapeutics in Q2 2013 and held it in 22 quarters.
- Bank of America's Kazia Therapeutics position peaked at $220K in Q1 2016.
- 17 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2023.
Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.